Board Certification

Internal Medicine

Endocrinology, Diabetes & Metabolism

Research

The elucidation of the mechanisms underlying the development of diabetes and prediabetes complications, with particular emphasis on diabetic cardiovascular autonomic and peripheral neuropathy, as well as the design and execution of clinical trials to test these mechanisms and to test novel therapies for preventing these complications in patients with type 1 and type 2 diabetes.

Rodica Pop-Busui M.D., Ph.D. is a Professor in the Department of Internal Medicine, Division of Metabolism, Endocrinology and Diabetes (MEND) and co-Director of the Neuropathy Center at the University of Michigan. She also leads the diabetes complications clinic at the University of Michigan. Dr. Pop-Busui received both M.D. and Ph.D. degrees summa cum laude from the University of Timisoara School of Medicine. Following residency training in general medicine and then internal medicine at the University Hospital in Timisoara, Romania, Dr Pop-Busui received a prestigious Fulbright Scholarship to continue postdoctoral training at the University of Michigan in the field of diabetes complications and joined the Division of Endocrinology and Diabetes (currently MEND) as a research fellow. She next completed clinical fellowship training in endocrinology and metabolism at the University of Michigan and joined the faculty at the University of Michigan in 2005.

Dr. Pop-Busui has concentrated her scholarship and research efforts on translational and clinical research focused in understanding the mechanisms of diabetic complications, particularly of diabetic peripheral neuropathy and cardiovascular autonomic neuropathy, and to understand their role in the development of the high cardiovascular risk complicating diabetes. As a result of her efforts, her research has been funded by the National Institute of Health/National Heart, Lung and Blood Institute, the American Diabetes Association, the Juvenile Diabetes Research Foundation, other foundations and industry. She also is and has been a PI or co-PI on several landmark diabetes trials funded by the National Institute of Health, such as the NHLBI-funded Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial, the NHLBI-funded Bypass Angioplasty Revascularization Investigation Type 2 Diabetes (BARI 2D) study, and the NIDDK-funded Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC).

Dr Pop-Busui received awards from the American Diabetes Association and the University of Michigan, has published numerous papers and book chapters, and is an expert in the management of diabetes complications.